Major heart attack study reveals ‘survival paradox’: Frail men at higher risk of death than women despite better treatment
Peer-Reviewed Publication
Updates every hour. Last Updated: 6-Jun-2026 03:15 ET (6-Jun-2026 07:15 GMT/UTC)
Most chronic diseases don’t begin with obvious symptoms or dramatic warning signs. Instead, they develop quietly over many years, as small changes accumulate in the body. A new perspective from researchers at the Buck Institute for Research on Aging notes that modern medicine often waits until disease is well underway, arguing that new technologies could help detect risk much earlier, when prevention may be most effective.
The human genome is a long sequence of DNA scattered with innumerable genetic variants that distinguish us. Extracting information from large biobank datasets about complex traits, influenced by thousands or millions of variants, remains a challenge. Using human height as a model, researchers at the Institute of Science and Technology Austria (ISTA) have now tackled this problem and developed an enhanced algorithm, published in Cell Genomics, with potential applications in personalized medicine—and even at crime scenes.
A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection.
An experimental vaccine administered to the mucosal lining of the colon protected against illness, death, tissue damage and infection recurrence. The findings, reported Feb. 18 in the journal Nature, represent a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection.
The University of Delaware's Juan Perilla is part of an international team that discovered a previously unknown role for the viral protein integrase, which helps HIV insert itself into human DNA. Reported in Nature, the discovery provides a new frontier for drug development to combat the virus.